Long-term follow-up of the EGEA cohort on respiratory and cardiac health
Official title: EGEA4: the 30-year Follow-up of the EGEA Study : Study of Markers of Cardiovascular Risk in Asthmatic and Non-asthmatic
Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06334705 · Data updated 2026-11-12
This study looks at how asthma might affect heart health over time by following a group of people and collecting different health information from them.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France Government |
| Locations | 5 sites (Grenoble and 4 other locations) |
| Status | Recruiting |
| Started | February 15, 2024 |
| Main results expected | February 15, 2027 |
| Study ends | February 15, 2028 |
| Registry record updated | September 19, 2025 |
| Trial ID | NCT06334705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have previously participated in the EGEA surveys and are affiliated with a social security scheme.
✕Probably not a fit
Patients who are currently deprived of liberty or under legal protection measures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the long-term follow-up of participants from the EGEA cohort to investigate the relationship between asthma and cardiovascular diseases. It aims to understand the potential shared risk factors and mechanisms linking these conditions, utilizing various interventions such as blood tests, food and hair collection, and calcium scans. The study seeks to gather comprehensive epidemiological data to better understand the impact of asthma on cardiovascular health over time.
Why it matters
Potential benefit: If successful, this study could provide insights that lead to improved prevention and treatment strategies for patients with asthma and cardiovascular diseases.
How similar studies have gone: Other studies have indicated a potential link between asthma and cardiovascular diseases, but this specific long-term follow-up approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have participated in at least one of the previous EGEA surveys; * to be affiliated to a social security scheme or to be a beneficiary of such a scheme. Exclusion Criteria: * Person deprived of liberty by judicial or administrative decision; * Person subject to a legal protection measure (safeguard of justice, curatorship or guardianship).
Where it's running
-
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, France Recruiting -
Hopital de la Croix Rousse
Lyon, France Recruiting -
Aphm
Marseille, France Recruiting -
Hôpital Arnaud De Villeneuve
Montpellier, France Recruiting -
APHP - Hôpital Bichat Claude Bernard
Paris, France Recruiting
Study contacts
- Principal investigator: Valérie Siroux, PHD — Institut National de la Santé Et de la Recherche Médicale, France
- Study coordinator: Valérie Siroux, PHD
- Email: valerie.siroux@univ-grenoble-alpes.fr
- Phone: 0476549451
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.